超越遗传学:解读误解变异在CAD缺陷中的影响
Francisco Del Caño-Ochoa1, Bobby G Ng2, Antonio Rubio-Del-Campo1
1Structure of Macromolecular Targets Unit, Instituto de Biomedicina de Valencia (IBV), CSIC, Valencia, Spain.
Journal of inherited metabolic disease
|August 4, 2023
概括
在CAD中的病理变异,对于胺合成至关重要,导致发育性脑病变. 这项研究确定了新的致病变体,并使用结构分析来改善受影响个体的诊断和尿液治疗.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学是一种遗传学.
- 结构生物学 结构生物学
背景情况:
- 碳酸合成酶2,酸转碳胺酶和二基酶 (CAD) 对于新兴的金胺生物合成至关重要.
- 病理性CAD变异导致发育性和性脑病变,可用尿素治疗,但由于众多变异和非特异性症状,诊断具有挑战性.
研究的目的:
- 评估未报告的误解CAD变异的致病性.
- 通过结合功能和结构分析来改善CAD缺陷的诊断工作流程.
- 了解致病性CAD变异的结构和功能影响,特别是在二甲酸酶 (DHO) 领域.
主要方法:
- 使用增长补充试验对20种未报告的误解CAD变体进行功能评估.
- 对9种先前报告的致病变体进行重新评估.
- 使用原子分辨率结构,功能测试和分子动力学模拟,对八种DHO域变体进行结构分析.
主要成果:
- 在7个个体中确定了11种致病性CAD变异,表明尿液治疗的潜在益处.
- 在9种先前报告的变种中,确认了7种变种的致病性,并将两种变种重新归类为可能良性的.
- 提供了全面的结构和功能洞察力,了解DHO域的活动,稳定性和受致病变体影响的寡合化.
结论:
- 功能和结构分析完善了对CAD变体致病性的理解.
- 这种方法可以改善CAD缺乏症的临床诊断工作流程,有助于及时有效的尿素补充.
- 强调计算方法的局限性,并强调需要进行综合功能和结构研究.
相关概念视频
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
39
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
39
Coronary Artery Disease III: Clinical Manifestations
13
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16


